14Dec
Financial Daily Dose 12.14.2020 | Top Story: AstraZeneca Acquires Alexion in $39 Billion Push into Immunology
Drugmaker AstraZeneca agreed on Saturday to buy biopharma company Alexion for $39 billion in cash and stock. In the deal—the “biggest by a health care company this year”—will help AstraZeneca expand into the immunology sector....
By:
Robins Kaplan LLP
Related
This week the National Labor Relations Board (“NLRB”) released the final version of its new standa...
Read More >
Private equity buyers have become a significant player in the healthcare M&A space and they continue...
Read More >
The Rhode Island Department of Environmental Management (DEM) announced today that $3 million is ava...
Read More >
The U.S. Court of Appeals for the Third Circuit has ruled that a Philadelphia city ordinance that pr...
Read More >
On December 20, 2019, President Trump signed a two-part spending bill funding the federal government...
Read More >
As “whistleblower” issues pervade national headlines, lawmakers in some jurisdictions, including N...
Read More >